Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-16-021506
Filing Date
2016-11-16
Accepted
2016-11-16 08:57:29
Documents
1
Period of Report
2016-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_147930463655077.html 3  
1 FORM 3 wf-form3_147930463655077.xml 3 2835
  Complete submission text file 0001628280-16-021506.txt   4534
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Issuer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE UNIVERSITY PLAZA, SUITE 307 HACKENSACK NJ 07601
Business Address
Breitfeld Philip P. (Reporting) CIK: 0001690133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11504 | Film No.: 162001410